Patent details

EP1178826 Title: IMMUNOTHERAPY OF B-CELL MALIGNANCIES USING ANTI-CD22 ANTIBODIES

Basic Information

Publication number:
EP1178826
PCT Application Number:
PCT/US/2000/012583
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP009304841
PCT Publication Number:
WO/2000/067795
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
IMMUNOTHERAPY OF B-CELL MALIGNANCIES USING ANTI-CD22 ANTIBODIES
French Title of Invention:
IMMUNOTHERAPIE DES MANIFESTATIONS MALIGNES DE LYMPHOCYTES B AU MOYEN D'ANTICORPS ANTI-CD22
German Title of Invention:
IMMUNTHERAPIE VON B-ZELL-MALIGNOMEN UNTER VERWENDUNG VON ANTIKÖRPERN GEGEN CD22
SPC Number:

Dates

Filing date:
10/05/2000
Grant date:
19/10/2016
EP Publication Date:
19/10/2016
PCT Publication Date:
16/11/2000
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
13/02/2002
EP B1 Publication Date:
19/10/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
10/05/2017
Expiration date:
10/05/2020
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
10/05/2000
 
 

Name:
Immunomedics Inc.
Address:
300 American Road, Morris Plains, NJ 07950, United States (US)

Inventor

Name:
GOLDENBERG David, M.
Address:
United States (US)

Priority

Priority Number:
307816
Priority Date:
10/05/1999
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 39/395;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages